Global Blood Therapeutics, Inc. Variable Lease, Cost
Global Blood Therapeutics, Inc. reported Variable Lease, Cost of $1.00 thousand for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2022-08-08
- Global Blood Therapeutics, Inc. variable lease, cost for the quarter ending 2022-06-30 was $1.00K, a 99.92% decline year-over-year.
- Global Blood Therapeutics, Inc. variable lease, cost for the quarter ending 2022-03-31 was $1.00K, a 99.86% decline year-over-year.
- Global Blood Therapeutics, Inc. variable lease, cost for the quarter ending 2021-12-31 was $900.00K, a 50.00% increase year-over-year.
- Global Blood Therapeutics, Inc. variable lease, cost for the quarter ending 2021-09-30 was $600.00K, a 14.29% decline year-over-year.
- Global Blood Therapeutics, Inc. variable lease, cost for fiscal 2021 was $3.50M, a 34.62% increase from fiscal 2020.
- Global Blood Therapeutics, Inc. variable lease, cost for fiscal 2020 was $2.60M, a 4.00% increase from fiscal 2019.
- Global Blood Therapeutics, Inc. variable lease, cost for fiscal 2019 was $2.50M.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2022-06-30 | $1.00K 10-Q · filed 2022-08-08 | $2.00M 10-Q · filed 2022-08-08 | $902.00K derived: sum of 3 quarters · filed 2022-08-08 | $1.50M derived: sum of 4 quarters · filed 2022-08-08 |
| 2022-03-31 | $1.00K 10-Q · filed 2022-05-04 | $901.00K derived: sum of 2 quarters · filed 2022-05-04 | $1.50M derived: sum of 3 quarters · filed 2022-05-04 | $2.70M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $1.50M derived: sum of 2 quarters · filed 2022-02-23 | $2.70M derived: sum of 3 quarters · filed 2022-08-08 | $3.50M 10-K · filed 2022-02-23 |
| 2021-09-30 | $600.00K 10-Q · filed 2021-11-04 | $1.80M derived: sum of 2 quarters · filed 2022-08-08 | $2.60M 10-Q · filed 2021-11-04 | $3.10M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-06-30 | $1.20M 10-Q · filed 2022-08-08 | $2.00M 10-Q · filed 2022-08-08 | $2.50M derived: sum of 3 quarters · filed 2022-08-08 | $3.20M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $700.00K 10-Q · filed 2022-05-04 | $1.30M derived: sum of 2 quarters · filed 2022-05-04 | $2.00M derived: sum of 3 quarters · filed 2022-05-04 | $2.60M derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $1.30M derived: sum of 2 quarters · filed 2022-02-23 | $1.90M derived: sum of 3 quarters · filed 2022-02-23 | $2.60M 10-K · filed 2022-02-23 |
| 2020-09-30 | $700.00K 10-Q · filed 2021-11-04 | $1.30M derived: sum of 2 quarters · filed 2021-11-04 | $2.00M 10-Q · filed 2021-11-04 | $2.70M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $600.00K 10-Q · filed 2021-08-03 | $1.30M 10-Q · filed 2021-08-03 | $2.00M derived: sum of 3 quarters · filed 2021-08-03 | $2.40M derived: sum of 4 quarters · filed 2021-08-03 |
| 2020-03-31 | $700.00K 10-Q · filed 2021-05-05 | $1.40M derived: sum of 2 quarters · filed 2021-05-05 | $1.80M derived: sum of 3 quarters · filed 2021-05-05 | $2.20M derived: sum of 4 quarters · filed 2021-05-05 |
| 2019-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $1.10M derived: sum of 2 quarters · filed 2021-02-24 | $1.50M derived: sum of 3 quarters · filed 2021-02-24 | $2.50M 10-K · filed 2021-02-24 |
| 2019-09-30 | $400.00K 10-Q · filed 2020-11-05 | $800.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.80M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $400.00K 10-Q · filed 2020-08-05 | $1.30M 10-Q · filed 2020-08-05 | ||
| 2019-03-31 | $900.00K 10-Q · filed 2020-05-06 |